The association of n-3 fatty acid intake with muscle mass and strength in older adults: A cross-sectional analysis of the UK biobank data
- PMID: 40580825
- DOI: 10.1016/j.jnha.2025.100622
The association of n-3 fatty acid intake with muscle mass and strength in older adults: A cross-sectional analysis of the UK biobank data
Abstract
Objectives: The main aim was to investigate the association of n-3 fatty acid intake and the n-6/n-3 fatty acid intake ratio with muscle mass and strength in older adults.
Methods: This study included 61,381 individuals (28,187 men and 33,194 women) aged ≥60 years. Grip strength and muscle mass index were assessed and n-3 and n-6 fatty acid intake were determined. Regression models adjusted for age, deprivation index, ethnicity, month of assessment, total energy intake, multimorbidity, lifestyle factors and physical activity. A sensitivity analysis was conducted in participants aged ≥65 years and in people with sarcopenia.
Results: Data are presented as trend for quintiles from fully adjusted models. Higher n-3 fatty acid intake was associated with a higher grip strength in both men (0.114 kg; 95% CI: 0.02 to 0.21) and women (0.115 kg; 95% CI: 0.05 to 0.18). Similar results were reported for grip strength index, with no associations observed for muscle mass index. No associations were seen in people ≥65 years. In people with sarcopenia no associations of n-3 fatty acid intake with grip strength or grip strength index were seen, but a positive association with muscle mass index was noted in men (0.197 kg/m²; 95% CI: 0.05 to 0.33). The n-6/n-3 fatty acid intake ratio was associated with grip strength in women (0.081 kg; 95% CI: -0.16 to 0.000) and with muscle mass index in men (-0.016 kg/m²; 95% CI: -0.02 to 0.00), no other associations were observed. No associations were seen in people with sarcopenia or people ≥65 years.
Conclusion: Higher n-3 fatty acid intake, with no consistent association with the n-6/n-3 fatty acid intake, was modestly associated with grip strength, with effects varying by sex and age, suggesting limited benefit for sarcopenia prevention at typical intake levels in older adults.
Keywords: Muscle mass; Muscle strength; Older adults; Sarcopenia; n-3 fatty acids.
Copyright © 2025 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
Corticosteroids for the treatment of Duchenne muscular dystrophy.Cochrane Database Syst Rev. 2016 May 5;2016(5):CD003725. doi: 10.1002/14651858.CD003725.pub4. Cochrane Database Syst Rev. 2016. PMID: 27149418 Free PMC article.
-
Effects of total fat intake on bodyweight in children.Cochrane Database Syst Rev. 2018 Jul 5;7(7):CD012960. doi: 10.1002/14651858.CD012960.pub2. Cochrane Database Syst Rev. 2018. PMID: 29974953 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
Effects of total fat intake on bodyweight in children.Cochrane Database Syst Rev. 2018 Feb 15;2(2):CD012960. doi: 10.1002/14651858.CD012960. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2018 Jul 05;7:CD012960. doi: 10.1002/14651858.CD012960.pub2. PMID: 29446437 Free PMC article. Updated.
-
Nutritional supplementation for stable chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD000998. doi: 10.1002/14651858.CD000998.pub3. Cochrane Database Syst Rev. 2012. PMID: 23235577 Free PMC article.
LinkOut - more resources
Full Text Sources